FDA Import Refusal SCS-4066844-9/10001/1 — CADILA PHARMACEUTICAL LTD
The FDA refused shipment SCS-4066844-9/10001/1 from CADILA PHARMACEUTICAL LTD (India) on Sep 29, 2025. The refused product falls under Drugs and Biologics — ROSUVASTATIN CALCIUM. Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Sep 29, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61JCA16 ROSUVASTATIN CALCIUM
- Charges
- 118,75